sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 1-25 out of 1407.

1 | 2 | 3 | 4 | 5 > >>

Public Release: 16-Oct-2017
American Journal of Tropical Medicine and Hygiene
Portable 3-D scanner assesses patients with elephantiasis
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Scientists at Washington University School of Medicine in St. Louis have shown that a portable scanning device can measure limb enlargement and disfigurement faster and more easily in patients with elephantiasis. The research tool makes it easy to obtain accurate measurements and determine whether treatments to reduce swelling are effective.
Washington University School of Medicine in St. Louis, US Agency for International Development

Contact: Diane Duke Williams
williamsdia@wustl.edu
314-286-0111
Washington University in St. Louis

Public Release: 13-Oct-2017
Emerging Microbes & Infections
Usutu virus is back -- not only in blackbirds but also in humans
During 10 subsequent years no Usutu virus associated bird mortality was observed in Austria - contrary to neighboring Hungary. Last year Usutu virus was identified again in two blackbirds - and in 2017 already in sixteen songbirds. A research team of the Vetmeduni Vienna investigated the virus strains involved. In another study Usutu virus was demonstrated in seven human blood donations from eastern Austria, suggesting that human infections seem to be more frequent than previously thought.

Contact: Norbert Nowotny
norbert.nowotny@vetmeduni.ac.at
971-522-054-070
University of Veterinary Medicine -- Vienna

Public Release: 12-Oct-2017
GeoHealth
Combination of El Niño and 2016 Ecuador earthquake likely worsened Zika outbreak
Combination of El Niño and 2016 Ecuador earthquake likely worsened Zika outbreak

Contact: Joseph Cariz
jcariz@agu.org
American Geophysical Union

Public Release: 12-Oct-2017
GeoHealth
CU Anschutz researchers say climate change may accelerate infectious disease outbreaks
Aside from inflicting devastating natural disasters on often vulnerable communities, climate change can also spur outbreaks of infectious diseases like Zika , malaria and dengue fever, according to a new study by researchers at the University of Colorado Anschutz Medical Campus.

Contact: David Kelly
david.kelly@ucdenver.edu
303-503-7990
University of Colorado Anschutz Medical Campus

Public Release: 12-Oct-2017
Current Microwave Chemistry
Microwave-assisted iodine-catalyzed rapid synthesis of 6H-indolo[2,3-b]quinolines
Indoloquinoline alkaloids are of great importance due to their unique structure and various biological activities. Several methods have been developed to synthesize indoloquinolines and among those, one-pot methods are of particular importance due to its simplified reaction procedure.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 12-Oct-2017
Call to Action on Antimicrobial Resistance
New UK-India scheme to tackle antimicrobial resistance announced
The Academy of Medical Sciences is today (Friday, 13th October) announcing the pledge from The Yusuf and Farida Hamied Foundation1 for a scheme to build stronger research links between the UK and India to jointly address the challenge of antimicrobial resistance (AMR).
Yusuf and Farida Hamied Foundation1

Contact: Naomi Clarke
naomi.clarke@acmedsci.ac.uk
020-314-13208
Academy of Medical Sciences (UK)

Public Release: 12-Oct-2017
Promising new leprosy vaccine moves into human trials
Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial in humans for a promising leprosy vaccine candidate -- the first vaccine developed specifically for leprosy.
American Leprosy Missions

Contact: Lee Schoentrup
Lee.Schoentrup@idri.org
206-858-6064
Infectious Disease Research Institute

Public Release: 11-Oct-2017
Lancet
New study mapping pandemic potential could help prevent future disease outbreaks
A new scientific study provides the first evidence-based assessment of pandemic potential in Africa prior to outbreaks and identifies ways to prevent them.
Bill & Melinda Gates Foundation

Contact: Dean Owen
dean1227@uw.edu
206-897-2858
Institute for Health Metrics and Evaluation

Public Release: 11-Oct-2017
New England Journal of Medicine
Experimental Ebola vaccines elicit year-long immune response
Results from a large randomized, placebo-controlled clinical trial in Liberia show that two candidate Ebola vaccines pose no major safety concerns and can elicit immune responses by one month after initial vaccination that last for at least one year. The findings, published in NEJM, are based on a study of 1,500 adults that began during the West Africa Ebola outbreak. The trial is being conducted by a US-Liberia clinical research collaboration known as PREVAIL.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIAIDNews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 10-Oct-2017
Scientific Reports
Research reveals how rabies can induce frenzied behavior
Scientists may finally understand how the rabies virus can drastically change its host's behavior to help spread the disease, which kills about 59,000 people annually. A new study published in the journal Scientific Reports shows how a small piece of the rabies virus can bind to and inhibit certain receptors in the brain that play a crucial role in regulating the behavior of mammals. This interferes with communication in the brain and induces frenzied behaviors that favor the transmission of the virus.

Contact: Meghan Murphy
mmmurphy3@alaska.edu
907-474-7541
University of Alaska Fairbanks

Public Release: 10-Oct-2017
Cell Reports
Better mini brains could help scientists identify treatments for Zika-related brain damage
UCLA researchers have developed an improved technique for creating simplified human brain tissue from stem cells. Because these so-called 'mini brain organoids' mimic human brains in how they grow and develop, they're vital to studying complex neurological diseases.
California Institute for Regenerative Medicine, California State University Northridge-UCLA Bridges, National Institutes of Health, Uehara Memorial Foundation, Ministry of Science, Research and Arts of Baden-Württemberg

Contact: Mirabai Vogt-James
mvogt@mednet.ucla.edu
310-983-1163
University of California - Los Angeles Health Sciences

Public Release: 10-Oct-2017
New Zika serotypes may emerge, researcher warns
The virus is mutating very fast in Brazilian patients. Appearance of new serotypes could hinder development of vaccines and efficacy of diagnostic tests, according to a member of one of the leading group of scientists on Zika-related investigations
Sao Paulo Research Foundation - FAPESP

Contact: Heitor Shimizu
heitor@fapesp.br
55-113-838-4223
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 10-Oct-2017
Journal of Molecular Biology
Parasite study paves way for therapies to tackle deadly infections
New understanding of a parasite that causes a million cases of disease each year could point towards effective drug treatments.
Wellcome, Scottish University Life Sciences Alliance, Biotechnology and Biological Sciences Research Council

Contact: Catriona Kelly
Catriona.Kelly@ed.ac.uk
44-779-135-5940
University of Edinburgh

Public Release: 10-Oct-2017
EP Europace
Smartphone apps launched for atrial fibrillation patients and their healthcare providers
Novel smartphone and tablet applications (apps) for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace,1 with a summary published in the European Heart Journal.2

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 10-Oct-2017
Virulence
A step towards a new drug to treat fungal infections that kill 1.6 million people annually
A team from Sydney's Westmead Institute for Medical Research is a step closer to developing a drug to treat life-threatening fungal infections that cause more than 1.6 million deaths annually.

Contact: Leesa Maroske
leesa.maroske@sydney.edu.au
61-286-273-030
Westmead Institute for Medical Research

Public Release: 10-Oct-2017
48th Union World Conference on Lung Health
TB Alliance moves two novel tuberculosis drugs into human trials
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted 'Investigative New Drug' status by the US Food and Drug Administration. The phase 1 clinical trials are presently ongoing.

Contact: CJ Volpe
CJ.Volpe@tballiance.org
973-303-2522
Burness

Public Release: 9-Oct-2017
Antimicrobial Agents and Chemotherapy
TGen sequencing test enables precise identification of drug-resistant TB
Two studies led by the Translational Genomics Research Institute (TGen) and the University of California San Francisco (UCSF) document how a new advanced genetic sequencing approach can help thwart the growing worldwide threat posed by drug-resistant mutations of tuberculosis (TB). The threat of TB is increasing in some places as mutant versions of the disease become more and more resistant to current drug treatments.
Doris Duke Charitable Foundation, NIH/National Institute of Allergy and Infectious Disease

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 9-Oct-2017
RIT to develop hybrid biological cell separations technology for lab-on-chip devices
Research being done at Rochester Institute of Technology to refine lab-on-chip devices -- highly sophisticated laboratories on microchips -- will provide more detailed and timely information to detect diseases such as cancer.
National Science Foundation

Contact: Michelle Cometa
macuns@rit.edu
585-475-4954
Rochester Institute of Technology

Public Release: 9-Oct-2017
Lancet Global Health
HIV: The benefits of prophylaxis of tuberculosis are confirmed
Long-term follow-up in the ANRS TEMPRANO trial confirms that tuberculosis chemoprophylaxis in HIV-infected people is more than ever relevant in resource-limited countries.
ANRS, Site ANRS côte d'ivoire, Inserm, Université de bordeaux

Contact: ANRS press contact
information@anrs.fr
01-539-46030
ANRS

Public Release: 9-Oct-2017
The Lancet Global Health
Indian government needs to do more to tackle rising sale of unapproved antibiotics
In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of London (QMUL) and Newcastle University. The correspondence published in The Lancet Global Health highlights serious hurdles for controlling antimicrobial resistance in the country.

Contact: Joel Winston
j.winston@qmul.ac.uk
44-207-882-7943
Queen Mary University of London

Public Release: 9-Oct-2017
Ecosphere
Study warns of pumpkin-colored zombies
Salt marsh research shows that growing abundance of tiny shrimp infected by a microscopic parasite may portend future threats to humankind through disease.
National Science Foundation, Northeast Climate Science Center

Contact: David Malmquist
davem@vims.edu
804-684-7011
Virginia Institute of Marine Science

Public Release: 7-Oct-2017
IDWeek 2017
US Olympians at the 2016 Rio Games were infected with West Nile virus, not Zika
US Olympic and Paralympic athletes and staff who traveled to Rio de Janeiro, Brazil, for the 2016 Summer Games did not become infected with Zika virus but did test positive for other tropical, mosquito-borne viral infections, including West Nile Virus, Dengue Fever and Chikungunya. Results from the University of Utah Health-led study will be reported on Oct. 7 at IDWeek, a national infectious disease conference being held in San Diego.
National Institutes of Health

Contact: Julie Kiefer
julie.kiefer@hsc.utah.edu
801-597-4258
University of Utah Health

Public Release: 6-Oct-2017
Circulation
Preeclampsia triggered by an overdose of gene activity
Preclampsia, the most dangerous form of hypertension during a pregnancy, is known to originate in the placenta. But the root causes remain largely a mystery. Findings from MDC scientists reveal that it is not a single disease caused solely by genetic factors: Epigenetically regulated genes play an important role. The Berlin research team also developed an in vitro model of the disorder which demonstrates the dysregulation of an important transcription factor.

Contact: Martin Ballaschk
martin.ballaschk@mdc-berlin.de
49-309-406-3714
Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Public Release: 5-Oct-2017
Research identifies potential targets for treatment of leishmaniasis
Brazilian scientists show that parasite's penetration of host cells increases expression of certain microRNAs capable of inhibiting action of immune system.
Sao Paulo Research Foundation - FAPESP

Contact: Heitor Shimizu
heitor@fapesp.br
55-113-838-4223
Fundação de Amparo à Pesquisa do Estado de São Paulo

Public Release: 5-Oct-2017
Science Translational Medicine
Monoclonal antibodies against zika show promise in monkey study
Using blood samples from an individual previously infected with Zika virus, NIAID-supported scientists, have developed an antibody-based Zika virus therapeutic that protected monkeys from infection. Because monoclonal antibodies are generally safe, they believe that this antibody cocktail might be appropriate for uninfected pregnant women; because the antibodies will likely cross the placenta, the researchers hope that administration during pregnancy may protect both the pregnant woman and the fetus from Zika virus.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Showing releases 1-25 out of 1407.

1 | 2 | 3 | 4 | 5 > >>